scholarly journals Burden of caregiving: Evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis

2004 ◽  
Vol 51 (4) ◽  
pp. 570-577 ◽  
Author(s):  
Werner B. F. Brouwer ◽  
N. Job A. van Exel ◽  
Bernard van de Berg ◽  
Huib J. Dinant ◽  
Marc A. Koopmanschap ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Informal Caregivers ◽  
Subjective Burden ◽  
Objective Burden

139 EVIDENCE OF OBJECTIVE BURDEN, SUBJECTIVE BURDEN, AND QUALITY OF LIFE IMPACTS ON INFORMAL CAREGIVERS OF FRAIL OLDER PERSONS WHO FALL

2010 ◽  
Vol 16 ◽  
pp. S40
Author(s):  
M. Faes ◽  
M.F. Reelick ◽  
B.W.M. Schalk ◽  
E. Ek ◽  
R.A. Esselink ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Older Persons ◽  
Informal Caregivers ◽  
Subjective Burden ◽  
Frail Older Persons ◽  
Objective Burden

scholarly journals Relationship between subjective and objective burden in family caregivers of Alzheimer patients

2017 ◽  
Vol 3 (1) ◽  
pp. 41 ◽  
Author(s):  
José Manuel Ponsoda Tornal ◽  
Amelia Díaz Martínez
Keyword(s):  
Quality Of Life ◽  
Social Support ◽  
Family Caregivers ◽  
Satisfaction With Life ◽  
Coping Styles ◽  
Satisfaction With Life Scale ◽  
Subjective Burden ◽  
Mediating Role ◽  
Objective Burden

The aim of this work is to determine the role that social support, coping, optimism, quality of life, resilience and life satisfaction have on the relationship between objective and subjective burden on family caregivers of Alzheimer patients. Method: Participants: 140 caregivers of Alzheimer patients. Instruments: Sociodemographic Data; CBI Caregiver Burden Scale; COPE Coping Styles Scale; DUKE.UNC Social Support Scale; LOT-R, Life Orientation TestRevised; QOLLTI-F, Quality of Life in Life Threatening Illness Scale–Family Carers Version; CD-RISC, Connor-Davidson Resilience Scale; SWLS, Satisfaction with Life Scale. Procedure: Implementation of scales in an individual, voluntary, anonymous way, including informed consent. Results: All variables studied produced significant differences between caregivers with high and low subjective burden, except time caring measured in months/years. Relationships between the variables were significant, with the exception of months/years caring and coping styles. Social support, optimism, satisfaction and quality of life have an important mediating role between objective and subjective burden. Conclusions and discussion: Social support, optimism, satisfaction and quality of life have been decisive as mediating variables between hours a day taking care (objective burden) and subjective burden. This result represents a step forward in the analysis and subsequent creation of intervention programs in family caregivers.

Tocilizumab Boosted Quality Of Life in Rheumatoid Arthritis

2008 ◽  
Vol 7 (5) ◽  
pp. 6
Author(s):  
NANCY WALSH
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis

Effects of depression and anxiety on quality of life of patients with rheumatoid arthritis, knee osteoarthritis and fibromyalgia syndrome

2007 ◽  
Vol 56 (2) ◽  
Author(s):  
A Ozcetin ◽  
S Ataoglu ◽  
E Kocer ◽  
S Yazycy ◽  
O Yildiz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Knee Osteoarthritis ◽  
Fibromyalgia Syndrome ◽  
Depression And Anxiety

Psychosomatic Features, Compliance and Complementary Therapies in Rheumatoid Arthritis

2020 ◽  
Vol 16 (3) ◽  
pp. 215-223
Author(s):  
Rostislav A. Grekhov ◽  
Galina P. Suleimanova ◽  
Andrei S. Trofimenko ◽  
Liudmila N. Shilova
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Interpersonal Relationships ◽  
Behavioral Therapy ◽  
Current Data ◽  
Psychotherapeutic Interventions ◽  
And Coping ◽  
Regulation Of Emotion ◽  
The Impact

This review highlights the issue of psychosomatic conditions in rheumatoid arthritis, paying special attention to new researches and trends in this field. Emerging concepts in all the major parts of the problem are covered consecutively, from the impact of chronic musculoskeletal pain on the emotional state to disease influence over quality of life, socio-psychological, and interpersonal relationships. Chronic pain is closely related to emotional responses and coping ability, with a pronounced positive effect of psychotherapeutic interventions, family and social support on it. Psychosexual disorders, anxiety, depression also commonly coexist with rheumatoid arthritis, leading to further decrease in quality of life, low compliance, and high suicide risk. Influence of psychosomatic conditions on the overall treatment effect is usually underestimated by rheumatologists and general practitioners. Psychosomatic considerations are of great importance for up-to-date management of rheumatoid arthritis, as they strongly influence the quality of life, compliance, and thereby disease outcomes. Two major approaches of psychological rehabilitation exist, both coping with pain through the regulation of emotion and psychotherapeutic intervention, which not only helps patients in coping with the disease, but also aimed at improving the overall adaptation of the patient. It includes techniques of relaxation, cognitive-behavioral therapy, and biofeedback therapy. Current data about the efficacy of the additional correcting therapies for patients with rheumatoid arthritis, both emerging and common ones, are discussed in the review.

Evaluating the efficacy of intra-articular injections of platelet rich plasma (PRP) in rheumatoid arthritis patients and its impact on inflammatory cytokines, disease activity and quality of life.

2020 ◽  
Vol 16 ◽  
Author(s):  
Dalia S. Saif ◽  
Nagwa N. Hegazy ◽  
Enas S. Zahran
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Disease Activity ◽  
Inflammatory Cytokines ◽  
Platelet Rich Plasma ◽  
Joint Inflammation ◽  
Monthly Interval ◽  
Post Injection ◽  
Tnf Α

Background: Among rheumatoid arthritis patients (RA), general disease activity is well regulated by diseasemodifying anti-rheumatic medications (DMARDS), but sometimes local inflammation still persists among a few joints. Adjuvant modern molecular interventions as Platelet Rich Plasma (PRP) with a suggested down regulating effect on inflammatory mediators has a proven effect in management of RA. We aim to evaluate the therapeutic effect of intra-articular PRP versus steroid in RA patients and their impact on inflammatory cytokines IL1B , TNF α, local joint inflammation, disease activity and quality of life (QL). Methods: Open labeled parallel randomized control clinical trial was carried out on 60 RA patients randomly divided into 2 groups, Group 1: included 30 patients received 3 intra-articular injections of PRP at monthly interval, Group 2: included 30 patients received single intra-articular injection of steroid. They were subjected to clinical, laboratory, serum IL1B and TNF α assessment at baseline and at 3, 6 months post injection. Results: Patients of both groups showed improvements in their scores of evaluating tools at 3months post injection and this improvement was persistent in the PRP group up to 6 months post injection while it was continued only for 3 months in the steroid group. Conclusions: PRP is a safe, effective and useful therapy in treating RA patients who had insufficient response and persistent pain and inflammation in just one or two joints through its down regulating effect on inflammatory cytokines IL1B, TNF α with subsequent improvement of local joint inflammation, disease activity and QL.

scholarly journals Evaluating the provision of Further Enabling Care at Home (FECH+) for informal caregivers of older adults discharged home from hospital: protocol for a multicentre randomised controlled trial

BMJ Open ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. e046600
Author(s):  
Anne-Marie Hill ◽  
Rachael Moorin ◽  
Susan Slatyer ◽  
Christina Bryant ◽  
Keith Hill ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Older Adults ◽  
Randomised Controlled Trial ◽  
Usual Care ◽  
Controlled Trial ◽  
Informal Caregivers ◽  
Care Recipient ◽  
Care At Home ◽  
Randomised Controlled

IntroductionThere are personal and societal benefits from caregiving; however, caregiving can jeopardise caregivers’ health. The Further Enabling Care at Home (FECH+) programme provides structured nurse support, through telephone outreach, to informal caregivers of older adults following discharge from acute hospital care to home. The trial aims to evaluate the efficacy of the FECH+ programme on caregivers’ health-related quality of life (HRQOL) after care recipients’ hospital discharge.Methods and analysisA multisite, parallel-group, randomised controlled trial with blinded baseline and outcome assessment and intention-to-treat analysis, adhering to Consolidated Standards of Reporting Trials guidelines will be conducted. Participants (N=925 dyads) comprising informal home caregiver (18 years or older) and care recipient (70 years or older) will be recruited when the care recipient is discharged from hospital. Caregivers of patients discharged from wards in three hospitals in Australia (one in Western Australia and two in Queensland) are eligible for inclusion. Participants will be randomly assigned to one of the two groups. The intervention group receive the FECH+ programme, which provides structured support and problem-solving for the caregiver after the care recipient’s discharge, in addition to usual care. The control group receives usual care. The programme is delivered by a registered nurse and comprises six 30–45 min telephone support sessions over 6 months. The primary outcome is caregivers’ HRQOL measured using the Assessment of Quality of Life—eight dimensions. Secondary outcomes include caregiver preparedness, strain and distress and use of healthcare services. Changes in HRQOL between groups will be compared using a mixed regression model that accounts for the correlation between repeated measurements.Ethics and disseminationParticipants will provide written informed consent. Ethics approvals have been obtained from Sir Charles Gairdner and Osborne Park Health Care Group, Curtin University, Griffith University, Gold Coast Health Service and government health data linkage services. Findings will be disseminated through presentations, peer-reviewed journals and conferences.Trial registration numberACTRN12620000060943.

Assessing drug impact on quality of life in rheumatoid arthritis

1990 ◽  
Vol &NA; (726) ◽  
pp. 14-15
Author(s):  
&NA;
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis
Sign in / Sign up

Export Citation Format

Share Document